Royalty Pharma plc (RPRX) Insider Trading

Name: Royalty Pharma plc (RPRX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 5, 2026): Marshall Urist (EVP, Research & Investments): Sale of 4,126 shares, $235.6K.

Get alerted when insiders trade RPRX

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta